Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03128853 · ClinicalTrials.gov registry record · NA
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT03128853: Completed NA study, sponsored by Masimo Corporation.
NCT03128853 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03128853, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
Single-arm study to investigate the repeatability and reproducibility of SpHb measurements from the Rad-67 and DCI Mini sensor.
Primary Outcome
The Repeatability and Reproducibility of the sensor will be assessed by varying the testing conditions (operator/device, finger, subject, and repetition) to determine the device and sensor's precision in SpHb measurements.
Interventions
- DEVICE Rad-67 and DCI Mini Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-10-31 |
| Est. Completion | 2016-11-15 |
| Phase | NA |
What the finished NCT03128853 record still lists
NCT03128853 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Rad-67 and DCI Mini Sensor is the first listed.
NCT03128853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03128853 about?
NCT03128853 is a clinical study titled "Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility". Single-arm study to investigate the repeatability and reproducibility of SpHb measurements from the Rad-67 and DCI Mini sensor.
What is the current status of trial NCT03128853?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2016-10-31. Estimated completion is 2016-11-15.
What interventions are being tested in trial NCT03128853?
The interventions under investigation include: Rad-67 and DCI Mini Sensor (DEVICE).
Who is sponsoring clinical trial NCT03128853?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03128853's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI